A carregar...
Progression of targeted therapy in advanced cholangiocarcinoma
It is necessary to establish an effective therapy to improve the survival of patients with advanced cholangiocarcinoma (CCA). Recently, with the development of pathology research in CCA, a lot of special bio-markers such as EGFR, VEGF, HER2, and MEK et al. could be over expression or mutations in CC...
Na minha lista:
| Publicado no: | Chin J Cancer Res |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
AME Publishing Company
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4409969/ https://ncbi.nlm.nih.gov/pubmed/25937773 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.1000-9604.2015.04.01 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|